4.7 Article

The network structure of core depressive symptom-domains in major depressive disorder following antidepressant treatment: a randomized clinical trial

Journal

PSYCHOLOGICAL MEDICINE
Volume 51, Issue 14, Pages 2399-2413

Publisher

CAMBRIDGE UNIV PRESS
DOI: 10.1017/S0033291720001002

Keywords

Antidepressant treatment; depressive symptoms; major depression; network analysis

Funding

  1. NARSAD Distinguished Investigator Award
  2. Canadian Institute of Health Research (CIHR)
  3. FRQS through the Quebec Network on Suicide, Mood Disorders and Related Disorders
  4. Pfizer

Ask authors/readers for more resources

The study found that the psychopathological network structure of major depressive disorder changed after 8 weeks of antidepressant treatment, showing increased interconnectedness. Throughout the treatment process, the core symptoms of major depressive disorder include depressed mood, fatigue, and cognitive/psychomotor disturbance.
Background Network analysis (NA) conceptualizes psychiatric disorders as complex dynamic systems of mutually interacting symptoms. Major depressive disorder (MDD) is a heterogeneous clinical condition, and very few studies to date have assessed putative changes in its psychopathological network structure in response to antidepressant (AD) treatment. Methods In this randomized trial with adult depressed outpatients (n = 151), we estimated Gaussian graphical models among nine core MDD symptom-domains before and after 8 weeks of treatment with either escitalopram or desvenlafaxine. Networks were examined with the measures of cross-sectional and longitudinal structure and connectivity, centrality and predictability as well as stability and accuracy. Results At baseline, the most connected MDD symptom-domains were fatigue-cognitive disturbance, whereas at week 8 they were depressed mood-suicidality. Overall, the most central MDD symptom-domains at baseline and week 8 were, respectively, fatigue and depressed mood; in contrast, the most peripheral symptom-domain across both timepoints was appetite/weight disturbance. Furthermore, the psychopathological network at week 8 was significantly more interconnected than at baseline, and they were also structurally dissimilar. Conclusion Our findings highlight the utility of focusing on the dynamic interaction between depressive symptoms to better understand how the treatment with ADs unfolds over time. In addition, depressed mood, fatigue, and cognitive/psychomotor disturbance seem to be central MDD symptoms that may be viable targets for novel, focused therapeutic interventions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available